可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patient with chronic heart failure [J]. Circulation, 2002, 105(20):2392-2397.
[2] Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988, 322(6159):78-81.
[3] Remme WJ, Swedberg K. Task force for the Diagnosis and Treatment of Chronic Heart Failure of European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure[J]. Eur Heart J, 2001, 22(17):1527-1560.
[4] Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting[J]. J Am Coll Cardiol, 2001, 37(2):379-385.
[5] Horie H, Tsutamoto T, Ishimoto N, et al. Plasma brain natriuretic peptide as a biochemicalmarker for atrioventricular sequence in patientswith pacemakers[J]. PACE, 1999, 22(2):282-290.
[6] Zile MR, Blaustein AS, Shimizu G, et al. Right ventricular pacing reduces the rate of left ventricular relaxation and filling[J]. J Am Coll Cardiol, 1987, 10(3):702-709.
[7] Mark JB, Chetham PM. Ventricular pacing can induce hemodynamically significant mitral valve regurgitation[J]. Anesthesiology, 1991, 74(2):375-377.
[8] Lee MA, Dae MW, Langberg JJ, et al. Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology[J]. J Am Coll Cardiol, 1994, 24(1): 225-232.
[9] Tse HF, Lau CP. Long term effect of right ventricular pacing on myocardial perfusion and function[J]. J Am Coll Cardiol, 1997, 29(4):744-749.
[10]Nielsen JC, Bottcher M, Nielsen TT, et al. Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing-effect of pacing mode and rate[J]. J Am Coll Cardiol, 2000, 35(6):1453-1461.
[11]Sweeney MO, Shea JB, Fox V, et al. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators [J]. Heart Rhythm, 2004, 1(2):160-167.
[12]Mair J, Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure[J]. Clin Chem Lab Med, 2001, 39 (7):571